A detailed history of Catalio Capital Management, LP transactions in Natera, Inc. stock. As of the latest transaction made, Catalio Capital Management, LP holds 148,369 shares of NTRA stock, worth $30.3 Million. This represents 4.42% of its overall portfolio holdings.

Number of Shares
148,369
Previous 97,297 52.49%
Holding current value
$30.3 Million
Previous $16.4 Billion 45.3%
% of portfolio
4.42%
Previous 3.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$133.66 - $181.11 $6.83 Million - $9.25 Million
51,072 Added 52.49%
148,369 $23.9 Billion
Q2 2025

Aug 14, 2025

BUY
$132.23 - $171.87 $12.9 Million - $16.7 Million
97,297 New
97,297 $16.4 Billion

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Catalio Capital Management, LP Portfolio

Follow Catalio Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalio Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Catalio Capital Management, LP with notifications on news.